Equity Capital Markets

Company · CIK 1770121

Sana Biotechnology, Inc.

CIK1770121 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressWA
ListedSANA (Nasdaq)
First annual or quarterly report2021-03-24

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-293981
ShelfEffective
 2026-03-032026-04-132
333-277584
ShelfEffective
 2024-03-012025-08-075
333-266547
ShelfEffective
 2022-08-042024-02-084
333-252061
IPOFinal prospectus
 2021-01-132021-02-056

Filings

18
FiledFilingRegistrationAccession
2026-04-13424B5Shelf takedown 333-2939810001193125-26-153046
2026-03-03S-3ASRShelf registered 333-2939810001193125-26-088784
2025-08-07424B5Shelf takedown 333-2775840001193125-25-175493
2025-08-06424B5Shelf takedown 333-2775840001193125-25-174567
2025-05-08424B5Shelf takedown 333-2775840001193125-25-116035
2025-03-21EFFECTDeclared effective 333-2775849999999995-25-000728
2024-03-01S-3ASRShelf registered 333-2775840001193125-24-055908
2024-02-08424B5Shelf takedown 333-2665470001193125-24-028442
2024-02-07424B5Shelf takedown 333-2665470001193125-24-026790
2023-05-01EFFECTDeclared effective 333-2665479999999995-23-001167
2022-08-04S-3ASRShelf registered 333-2665470001193125-22-212687
2021-02-05424B4Final prospectus 333-2520610001193125-21-029606
2021-02-03EFFECTDeclared effective 333-2520619999999995-21-000413
2021-02-03S-1/AAmendment 333-2520610001193125-21-026330
2021-02-02S-1/AAmendment 333-2520610001193125-21-025048
2021-01-28S-1/AAmendment 333-2520610001193125-21-019984
2021-01-13S-1Registration filed 333-2520610001193125-21-007483
2020-11-10DRSDraft made public 377-037680000950123-20-011218

All filings of this company · CSV